Evidence map›Paper›PMID 30140488›Full record

ArticleJournal of pharmaceutical analysis2018

Screening potential mitochondria-targeting compounds from traditional Chinese medicines using a mitochondria-based centrifugal ultrafiltration/liquid chromatography/mass spectrometry method.

Xing-Xin Yang, Yu-Zhen Zhou, Feng Xu, Jie Yu, Gegentana, Ming-Ying Shang, Xuan Wang, Shao-Qing Cai

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xing-Xin YangDepartment of Natural Medicines, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China.
Yu-Zhen ZhouDepartment of Chemical Biology, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China.
Feng XuDepartment of Natural Medicines, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China.
Jie YuCollege of Pharmaceutical Science, Yunnan University of Traditional Chinese Medicine, 1076 Yuhua Road, Kunming 650500, Yunnan Province, PR China.
GegentanaDepartment of Natural Medicines, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China.
Ming-Ying ShangDepartment of Natural Medicines, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China.
Xuan WangDepartment of Chemical Biology, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China.
Shao-Qing CaiDepartment of Natural Medicines, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, PR China.
Peking University · CNYunnan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria regulate numerous crucial cell processes, including energy production, apoptotic cell death, oxidative stress, calcium homeostasis and lipid metabolism. Here, we applied an efficient mitochondria-based centrifugal ultrafiltration/liquid chromatography/mass spectrometry (LC/MS) method, also known as screening method for mitochondria-targeted bioactive constituents (SM-MBC). This method allowed searching natural mitochondria-targeting compounds from traditional Chinese medicines (TCMs), including Puerariae Radix (PR) and Chuanxiong Radix (CR). A total of 23 active compounds were successfully discovered from the two TCMs extracts. Among these 23 hit compounds, 17 were identified by LC/MS, 12 of which were novel mitochondria-targeting compounds. Among these, 6 active compounds were analyzed in vitro for pharmacological tests and found able to affect mitochondrial functions. We also investigated the effects of the hit compounds on HepG2 cell proliferation and on loss of cardiomyocyte viability induced by hypoxia/reoxygenation injury. The results obtained are useful for in-depth understanding of mechanisms underlying TCMs therapeutic effects at mitochondria level and for developing novel potential drugs using TCMs as lead compounds. Finally, we showed that SM-MBC was an efficient protocol for the rapid screening of mitochondria-targeting constituents from complex samples such as PR and CR extracts.

Indexed as

Bioactive constituentsCentrifugal ultrafiltrationLiquid chromatography/mass spectrometryMitochondriaTraditional Chinese medicines

Identifiers

PMID30140488
PMCPMC6104153
OpenAlexW2808554014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.